Structure-function of human 3α-hydroxysteroid dehydrogenases: Genes and proteins

Molecular and Cellular Endocrinology

Volumn 215, Issue 1-2, 2004, Pages 63-72

  Penning, T M ^a   Jin, Y ^a   Steckelbroeck, S ^a   Rižner, T Lanišnik ^a,c   Lewis, M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

3 diol; 3 hydroxy 5 androstan 17 one; 5 androstane 3 ,17 diol; 5 DHT; 5 dihydrotestosterone; AKR; Aldo keto reductase; Androsterone; DD; Dihydrodiol dehydrogenase; HSD; Hydroxysteroid dehydrogenase

Indexed keywords

17 HYDROXYSTEROID DEHYDROGENASE; 17 OXOSTEROID; 17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 5; 17BETA HYDROXYSTEROID OXIDASE; 20 OXOSTEROID REDUCTASE; 20ALPHA HYDROXYSTEROID OXIDASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE TYPE 1; 3ALPHA HYDROXYSTEROID DEHYDROGENASE TYPE 2; 3ALPHA HYDROXYSTEROID DEHYDROGENASE TYPE 3; 3ALPHA HYDROXYSTEROID OXIDASE; ALDO KETO REDUCATSE 1C4; ALDO KETO REDUCTASE 1C1; ALDO KETO REDUCTASE 1C2; ALDO KETO REDUCTASE 1C3; ANDROGEN RECEPTOR; BILE ACID BINDING PROTEIN; BINDING PROTEIN; ENZYME; ESTROGEN RECEPTOR; HYDROXYSTEROID; ISOPROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; OXOSTEROID; PROGESTERONE RECEPTOR; PROTEIN; RECOMBINANT ENZYME; STEROID REDUCTASE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

AMINO ACID SEQUENCE; BINDING AFFINITY; CATALYSIS; CELL STRAIN COS1; CHEMICAL REACTION; CONFERENCE PAPER; CRYSTAL STRUCTURE; ENZYME ACTIVITY; GENE; HORMONE ACTION; HORMONE METABOLISM; HUMAN; IN VITRO STUDY; LIVER; MOLECULAR CLONING; MOLECULAR RECOGNITION; NONHUMAN; PH; PLASTICITY; PRIORITY JOURNAL; PROSTATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLUBILITY; STEADY STATE; STRESS; TARGET ORGAN;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; EXONS; HUMANS; INTRONS; ISOENZYMES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1542725957     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.11.006     Document Type: Conference Paper

References (46)

1. Arnett-Mansfield R., deFazio A., Wain G.V., Jaworski R.C., Byth K., Motte P.A., Clarke C.L. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res. 61:2001;4576-4582.
2. Askonas L.J., Ricigliano J.W., Penning T.M. The kinetic mechanism catalysed by homogeneous rat liver 3α-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. Biochem. J. 278(Part 3):1991;835-841.
3. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., Bulun S.E. Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab. 85:2000;2897-2902.
4. Barbieri R.L. Endometriosis 1990. Current treatment approaches. Drugs. 39:1990;502-510.
5. +. Biochemistry. 35:1996;10702-10711.
6. + bound to 3α-hydroxysteroid/dihydrodiol dehydrogenase. Structure. 5:1997;799-812.
7. Burczynski M.E., Harvey R.G., Penning T.M. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. Biochemistry. 37:1998;6781-6790.
8. Burczynski M.E., Lin H.-K., Penning T.M. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenases. Cancer Res. 59:1999;607-614.
9. Debas J.D., Tindall D.J. The role of androgens and the androgen receptor in prostate cancer. Cancer Lett. 187:2002;1-7.
10. Deyashiki Y., Taniguchi H., Amano T., Nakayama T., Hara A., Sawada H. Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3α-hydroxysteroid dehydrogenase activity. Biochem. J. 282:1992;741-746.
11. Deyashiki Y., Ogasawara A., Nakayama T., Nakanishi M., Miyabe Y., Sato K., Hara A. Molecular cloning of two human liver 3α-hydroxysteroid/ dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. Biochem. J. 299(Part 2):1994;545-552.
12. Dufort I., Soucy P., Labrie F., Luu-The V. Molecular cloning of human type 3 3α-hydroxysteroid dehydrogenase that differs from 20α-hydroxysteroid dehydrogenase by seven amino acids. Biochem. Biophys. Res. Commun. 228:1996;474-479.
13. Dufort I., Rheault P., Huang X.-F., Soucy P., Luu-The V. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology. 140:1999;568-574.
14. Dufort I., Labrie F., Luu-The V. Human types 1 and 3 3α- hydroxysteroid dehydrogenases: differential lability and tissue distribution. J. Clin. Endocrinol. Metab. 86:2001;841-846.
15. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors directly alter the activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;13512-13517.
16. Grimshaw C.E., Bohren K.M., Lai C.J., Gabbay K.H. Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. Biochemistry. 34(44):1995;14356-14365.
17. Hara A., Taniguchi H., Nakayama T., Sawada H. Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J. Biochem. (Tokyo). 108:1990;250-254.
18. Hara A., Matsuura K., Tamada Y., Sato K., Miyabe Y., Deyashiki Y., Ishida N. Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochem. J. 313:1996;373-376.
19. Hoog S.S., Pawlowski J.E., Alzari P.M., Penning T.M., Lewis M. Three-dimensional structure of rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc. Natl. Acad. Sci. U.S.A. 91(7):1994;2517-2521.
20. Hou Y.T., Lin H.-K., Penning T.M. Dexamethasone regulation of the rat 3α-hydroxysteroid/dihydrodiol dihydrogenase (3α-HSD/DD) gene. Mol. Pharmacol. 53:1997;459-466.
21. Hung C.-F., Penning T.M. Members of the nuclear factor 1 transcription factor family regulate rat 3α-hydroxysteroid/dihydrodiol dehydrogenase (3α-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily. Mol. Endocrinol. 13:1999;1704-1717.
22. Jez J.M., Penning T.M. Engineering steroid 5β-reductase activity into rat liver 3α-hydroxysteroid dehydrogenase. Biochemistry. 37:1998;9695-9703.
23. Jez J.M., Flynn T.G., Penning T.M. A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54:1997;639-647.
24. + and ursodeoxycholate. Biochemistry. 40:2001;10161-10168.
25. Khanna M., Qin K.N., Klisak I., Belkin S., Sparkes R.S., Cheng K.C. Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization. Genomics. 25(2):1995;588-590.
26. Khanna M., Qin K.N., Wang R.W., Cheng K.C. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J. Biol. Chem. 270:1995;20162-20168.
27. A receptor complex: electrophysiological studies. Steroids and neuronal activity. In: Proceedings of the Ciba Foundation Symposium, vol. 153. Wiley, Chichester, 1990, pp. 56-82.
28. A receptor function. Trends Pharmacol. Sci. 16(9):1995;295-303.
29. Liao S., Liang T., Fang S., Castaneda E., Shao T.C. Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. J. Biol. Chem. 248(17):1973;6154-6162.
30. Lin H.-K., Penning T.M. Cloning, sequencing, and functional analysis of the 5′-flanking region of the rat 3α-hydroxysteroid/dihydrodiol dehydrogenase gene. Cancer Res. 55(18):1995;4105-4113.
31. Lin H.-K., Jez J.M., Schlegel B.P., Peehl D.M., Pachter J.A., Penning T.M. Expression and characterization of recombinant type 2 3α- hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3α(17β)-HSD activity and cellular distribution. Mol. Endocrinol. 11:1997;1971-1984.
32. Lin H.-K., Hung C.-F., Moore M., Penning T.M. Genomic structure of rat 3α-hydroxysteroid/dihydrodiol dehydrogenase (3α-HSD/DD,AKR1C9). J. Steroid Biochem. Mole. Biol. 71:1999;29-39.
33. Ma H., Penning T.M. Conversion of mammalian 3α-hydroxysteroid dehydrogenase to 20α-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11161-11166.
34. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232(4753):1986;1004-1007.
35. A receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
36. + at 1.25 A resolution. J. Biol. Chem. 276, 42091-42098.
37. Pawlowski J.E., Penning T.M. Overexpression and mutagenesis of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. J. Biol. Chem. 269:1994;13502-13510.
38. Pawlowski J.E., Huizinga M., Penning T.M. Cloning and sequencing of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. J. Biol. Chem. 266:1991;8820-8825.
39. Penning T.M., Mukharji I., Barrows S., Talalay P. Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem. J. 222(3):1984;601-611.
40. Penning T.M., Burczynski M.E., Jez J.M., Hung C.-F., Lin H.-K., Ma H., Moore M., Palackal N., Ratnam K. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351:2000;67-77.
41. Ratnam K., Ma H., Penning T.M. The arginine 276 anchor for NAD (P) H dictates fluorescence kinetic transients in 3α-hydroxysteroid dehydrogenase a representative aldo-keto reductase. Biochemistry. 38:1999;7856-7864.
42. Rice V.M. Conventional medical therapies for endometriosis. Ann. N. Y. Acad. Sci. 955:2002;343-352.
43. Rižner T.L., Lin H.-K., Penning T.M. Role of human type 3 3α-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. Chem. Biol. Inter. 143-144:2003a;401-409.
44. Rižner T., Lin H.-K., Peehl D.M., Steckelbroeck S., Bauman D.R., Penning T.M. Human type 3 3α-hydroxysteroid dehydrogenase (AKR1C2) and androgen metabolism in prostate cells. Endocrinology. 144:2003b;2922-2932.
45. Schlegel B.P., Jez J.M., Penning T.M. Mutagenesis of 3α- hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases. Biochemistry. 37:1998;3538-3548.
46. Stolz A., Hammond L., Lou H., Takikawa H., Ronk M., Shively J.E. cDNA cloning and expression of the human hepatic bile-acid-binding protein. A member of the monomeric reductase gene family. J. Biol. Chem. 268:1993;10448-10457.